Literature DB >> 27722555

Monitoring sepsis using electrical cell profiling.

Javier L Prieto1, Hao-Wei Su1, Han Wei Hou1, Miguel Pinilla Vera2, Bruce D Levy2, Rebecca M Baron2, Jongyoon Han1, Joel Voldman1.   

Abstract

Sepsis is a potentially lethal condition that may be ameliorated through early monitoring of circulating activated leukocytes for faster stratification of severity of illness and improved administration of targeted treatment. Characterization of the intrinsic electrical properties of leukocytes is label-free and can provide a quick way to quantify the number of activated cells as sepsis progresses. Iso-dielectric separation (IDS) uses dielectrophoresis (DEP) to characterize the electrical signatures of cells. Here, we use IDS to show that activated and non-activated leukocytes have different electrical properties. We then present a double-sided version of the IDS platform to increase throughput to characterize thousands of cells. This new platform is less prone to cell fouling and allows faster characterization. Using peripheral blood samples from a cecal ligation and puncture (CLP) model of polymicrobial sepsis in mice, we estimate the number of activated leukocytes by looking into differences in the electrical properties of cells. We show for the first time using animal models that electrical cell profiling correlates with flow cytometry (FC) results and that IDS is therefore a good candidate for providing rapid monitoring of sepsis by quantifying the number of circulating activated leukocytes.

Entities:  

Mesh:

Year:  2016        PMID: 27722555      PMCID: PMC5535304          DOI: 10.1039/c6lc00940a

Source DB:  PubMed          Journal:  Lab Chip        ISSN: 1473-0189            Impact factor:   6.799


  24 in total

1.  Time domain dielectric spectroscopy study of human cells. II. Normal and malignant white blood cells.

Authors:  Y Polevaya; I Ermolina; M Schlesinger; B Z Ginzburg; Y Feldman
Journal:  Biochim Biophys Acta       Date:  1999-07-15

2.  Measurements of the dielectric properties of peripheral blood mononuclear cells and trophoblast cells using AC electrokinetic techniques.

Authors:  K L Chan; H Morgan; E Morgan; I T Cameron; M R Thomas
Journal:  Biochim Biophys Acta       Date:  2000-03-17

Review 3.  The complete blood count: physiologic basis and clinical usage.

Authors:  L R Dixon
Journal:  J Perinat Neonatal Nurs       Date:  1997-12       Impact factor: 1.638

Review 4.  Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.

Authors:  M H Zweig; G Campbell
Journal:  Clin Chem       Date:  1993-04       Impact factor: 8.327

5.  Three-dimensional electric field traps for manipulation of cells--calculation and experimental verification.

Authors:  T Schnelle; R Hagedorn; G Fuhr; S Fiedler; T Müller
Journal:  Biochim Biophys Acta       Date:  1993-06-11

Review 6.  The immunopathogenesis of sepsis.

Authors:  Jonathan Cohen
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

7.  An equilibrium method for continuous-flow cell sorting using dielectrophoresis.

Authors:  M D Vahey; J Voldman
Journal:  Anal Chem       Date:  2008-03-26       Impact factor: 6.986

8.  Dielectrophoretic studies of the activation of human T lymphocytes using a newly developed cell profiling system.

Authors:  Ronald Pethig; Vincent Bressler; Catherine Carswell-Crumpton; Yan Chen; Linda Foster-Haje; Marcos E García-Ojeda; Richard S Lee; Gary M Lock; Mark S Talary; Keri M Tate
Journal:  Electrophoresis       Date:  2002-07       Impact factor: 3.535

9.  Broad spectrum immunomodulation using biomimetic blood cell margination for sepsis therapy.

Authors:  Han Wei Hou; Lidan Wu; Diana P Amador-Munoz; Miguel Pinilla Vera; Anna Coronata; Joshua A Englert; Bruce D Levy; Rebecca M Baron; Jongyoon Han
Journal:  Lab Chip       Date:  2016-01-15       Impact factor: 6.799

10.  Probing circulating tumor cells in microfluidics.

Authors:  Peng Li; Zackary S Stratton; Ming Dao; Jerome Ritz; Tony Jun Huang
Journal:  Lab Chip       Date:  2013-02-21       Impact factor: 6.799

View more
  8 in total

Review 1.  Point of care technologies for sepsis diagnosis and treatment.

Authors:  Taylor Oeschger; Duncan McCloskey; Varun Kopparthy; Ankur Singh; David Erickson
Journal:  Lab Chip       Date:  2019-02-26       Impact factor: 6.799

2.  Measurement of the low-frequency charge noise of bacteria.

Authors:  Yichao Yang; Hagen Gress; Kamil L Ekinci
Journal:  Phys Rev E       Date:  2022-06       Impact factor: 2.707

Review 3.  Point-of-Care Diagnostics: Recent Developments in a Connected Age.

Authors:  Samiksha Nayak; Nicole R Blumenfeld; Tassaneewan Laksanasopin; Samuel K Sia
Journal:  Anal Chem       Date:  2016-12-13       Impact factor: 6.986

4.  Electroporation Parameters for Human Cardiomyocyte Ablation In Vitro.

Authors:  Jara M Baena-Montes; Tony O'Halloran; Cormac Clarke; Kevin Donaghey; Eoghan Dunne; Martin O'Halloran; Leo R Quinlan
Journal:  J Cardiovasc Dev Dis       Date:  2022-07-28

Review 5.  Integrating molecular pathogenesis and clinical translation in sepsis-induced acute respiratory distress syndrome.

Authors:  Joshua A Englert; Christopher Bobba; Rebecca M Baron
Journal:  JCI Insight       Date:  2019-01-24

6.  Multi-frequency dielectrophoretic characterization of single cells.

Authors:  Alex Jaffe; Joel Voldman
Journal:  Microsyst Nanoeng       Date:  2018-09-10       Impact factor: 7.127

7.  Leukocyte function assessed via serial microlitre sampling of peripheral blood from sepsis patients correlates with disease severity.

Authors:  Bakr Jundi; Hyunryul Ryu; Do-Hyun Lee; Raja-Elie E Abdulnour; Braden D Engstrom; Melody G Duvall; Angelica Higuera; Mayra Pinilla-Vera; Maura E Benson; Jaemyon Lee; Nandini Krishnamoorthy; Rebecca M Baron; Jongyoon Han; Joel Voldman; Bruce D Levy
Journal:  Nat Biomed Eng       Date:  2019-11-11       Impact factor: 25.671

Review 8.  Lipid-Derived Mediators are Pivotal to Leukocyte and Lung Cell Responses in Sepsis and ARDS.

Authors:  Julie Nijmeh; Bruce D Levy
Journal:  Cell Biochem Biophys       Date:  2021-06-27       Impact factor: 2.194

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.